UPDATES

Brady Statement on Announcement of Intention to Nominate Amb. Robert Lighthizer to be United States Trade Representative

January 03, 2017 — Press Releases

WASHINGTON, D.C. – House Ways and Means Chairman Kevin Brady (R-TX) today released the following statement after President-elect Donald Trump announced his intention to nominate Robert Lighthizer to be the next United States Trade Representative (USTR). “Congratulations to Ambassador Lighthizer for being selected to serve as the next United ...

Brady Applauds USTR Action to Protect the U.S. Beef Industry From Unfair European Union Trade Practices

December 22, 2016 — Press Releases

WASHINGTON, D.C. — House Ways and Means Committee Chairman Kevin Brady (R-TX) issued the following statement regarding today’s announcement that the U.S. Trade Representative (USTR) is scheduling a public hearing and seeking public comments in connection with the European Union’s ban of U.S. beef products. “For years, the EU has denied ...

Brady, Roskam Send Letter Expressing Concern over Continued IRS Targeting of Pro-Israel Groups

December 19, 2016 — Press Releases

House Ways and Means Committee Chairman Kevin Brady (R-TX) and Oversight Subcommittee Chairman Peter Roskam (R-IL) sent a letter to the Internal Revenue Service (IRS) requesting information regarding the agency’s practice and policies when reviewing an organization’s application for tax-exempt status, specifically when the organization expresses support for the State of Israel. This letter is ...

THIS SUNDAY: Chairman Brady on C-SPAN’s Newsmakers

December 17, 2016 — Media Advisory

WASHINGTON, D.C. – On Sunday, December 18, 2016, at 10:00 a.m. EST, Ways and Means Committee Chairman Kevin Brady (R-TX) will appear on C-SPAN’s Newsmakers to discuss the recent Ways and Means Member policy retreat and the path forward on tax reform and health care.

Brady Statement on the Administration’s Departure From Medicare Experiment

December 16, 2016 — Press Releases

House Ways and Means Committee Chairman Kevin Brady (R-TX) issued the following statement regarding the Center for Medicare & Medicaid Innovation’s (CMMI) decision to abandon its Medicare Part B Drug Payment Model: “For months, members of Congress on both sides of the aisle voiced strong opposition to this misguided Medicare experiment because it would ...